{"altmetric_id":2184135,"counts":{"readers":{"mendeley":8,"citeulike":0,"connotea":0},"blogs":{"unique_users_count":1,"unique_users":[57235],"posts_count":1},"total":{"posts_count":1}},"citation":{"altmetric_jid":"4f6fa50b3cf058f610003166","authors":["Guy Gorochov","Jean-Philippe Deslys"],"doi":"10.1038\/nm0104-11a","endpage":"11","first_seen_on":"2014-03-13T21:33:00+00:00","issns":["ERROR! NO ISSN","ERROR! NO EISSN","1078-8956"],"issue":"1","journal":"Nature Medicine","last_mentioned_on":1394727060,"links":["http:\/\/staging-www.nature.com\/nm\/journal\/v10\/n1\/pdf\/nm0104-11a.pdf"],"pmid":"14702617","pubdate":"2004-01-01T00:00:00+00:00","publisher":"Nature Publishing Group","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"11","title":"Properties of a disease-specific prion probe","type":"article","volume":"10","mendeley_url":"http:\/\/www.mendeley.com\/research\/properties-diseasespecific-prion-probe"},"altmetric_score":{"score":5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":5},"context_for_score":{"all":{"total_number_of_other_articles":3631967,"mean":4.9253635474614,"rank":602832,"this_scored_higher_than_pct":83,"this_scored_higher_than":3015050,"rank_type":"exact","sample_size":3631967,"percentile":83},"similar_age_3m":{"total_number_of_other_articles":94052,"mean":7.3134221645705,"rank":17818,"this_scored_higher_than_pct":80,"this_scored_higher_than":75968,"rank_type":"exact","sample_size":94052,"percentile":80},"this_journal":{"total_number_of_other_articles":3430,"mean":14.136583843686,"rank":1759,"this_scored_higher_than_pct":48,"this_scored_higher_than":1655,"rank_type":"exact","sample_size":3430,"percentile":48},"similar_age_this_journal_3m":{"total_number_of_other_articles":91,"mean":37.813266666667,"rank":55,"this_scored_higher_than_pct":39,"this_scored_higher_than":36,"rank_type":"exact","sample_size":91,"percentile":39}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":1,"Researcher":2,"Student  > Ph. D. Student":4,"Professor":1},"by_discipline":{"Agricultural and Biological Sciences":3,"Biochemistry, Genetics and Molecular Biology":3,"Mathematics":1,"Arts and Humanities":1}}},"geo":{"mendeley":{"GB":1}}},"posts":{"blogs":[{"title":"Viral expression of antibodies in the brain as a therapeutic strategy in prion disease","url":"http:\/\/www.cureffi.org\/2014\/03\/13\/viral-expression-of-antibodies-in-the-brain-as-a-therapeutic-strategy-in-prion-disease\/","citation_ids":[1406717,1799761,1799761,2152700,2152700,2184128,2184129,1794268,1340462,2184130,2184131,2184132,2109372,2184133,2184134,2184135,2184076,2184136,2184137,2184137,2184138,2184139,2102613,167215,2184139,2184140,2184141,2184142,2102613,2102613],"posted_on":"2014-03-13T16:11:00+00:00","summary":"Last week Sonia and I sat down for a brainstorm session with the Harvard gene therapy researcher Luk Vandenberghe, on how to best get large biomolecules into the brain to treat prion diseases.  Hot off of doing much of the reading for my last post on CRISP","author":{"name":"CureFFI.org","url":"http:\/\/www.cureffi.org\/","description":"Not if, when."}}]}}